Skip to content

The Motley Fool

3 Top Growth ETFs To Buy Right Now

Investing in stocks doesn’t have to be overly complicated. Exchange-traded funds, or ETFs for short, offer many of the same benefits of owning individual stocks, but these vehicles come with the added bonus of instant diversification. As a result, ETFs can be a straightforward and simple way to gain exposure to the market, or a particular theme like artificial intelligence… 

3 AI ETFs That Could Help You Capitalize On The Artificial Intelligence Boom

Artificial intelligence (AI) is the hottest technology of 2023, with many stocks in the emerging industry absolutely surging year to date: But last year was a different story; many of these names suffered steep declines — in some cases of 50% or more — which is a reminder that big gains typically come with a higher degree of volatility. So… 

3 Red-Hot Growth Stocks To Buy Right Now

Growth stocks have been the talk of the town in 2023. Unlike stable dividend-paying companies, which tend to be established, many growth-orientated companies are valued based on what they will become in the future, not where they are in the present. Bullish stock markets coincide with investor optimism, which can help fuel a rally in growth stocks. These three stocks have… 

2 Market-Beating Stocks With Major Catalysts On The Way

For those seeking stocks that have trounced the market over the past year, the biotech sector might be an excellent place to start. The SPDR S&P Biotech Index ETF, an industry benchmark, has climbed 34% over the trailing-12-month period, nearly three times the gains of the S&P 500. These two drugmakers that have done particularly well for themselves. Moreover, both… 

3 AI Stocks That Could Help Set You Up For Life

Just today, artificial intelligence (AI) tricked me. I was listening to YouTube when a great cover of “Goodbye Yellow Brick Road” by Paul McCartney caught my attention.  The only catch? Sir Paul has never recorded the song — it was an AI creation. Yet, I, a Beatles mega-fan, couldn’t tell the difference.  The world is changing, and AI is a… 

The World’s Richest Person Just Lost $11 Billion In A Single Day. Here’s How

Elon Musk, Jeff Bezos, Bill Gates, and Warren Buffett are among the world’s most well-known billionaires. But Bernard Arnault (and his family) is actually the world’s richest person, according to Forbes. However, on May 23, Arnault lost a whopping $11 billion. Don’t feel too bad for Arnault — what lowered his net worth is the same force that made him the world’s… 

Will ChatGPT Replace Google? Here’s What We Know

ChatGPT has made headlines as a viral new technology. The chatbot using artificial intelligence (AI) can not only answer user questions with conversational replies, but it’s also the fastest-growing app in history. Since launching in late 2022, ChatGPT has grown to 1.6 billion visitors in just months. Microsoft has invested in OpenAI, the company behind ChatGPT, and integrated its technology into… 

3 Growth Stock Warning Signs You Shouldn’t Ignore

Growth stocks tend to be riskier than other stocks. As the saying goes, “You won’t grow without taking risks.” The wise long-term investor needs to understand this and also needs to have a firm understanding of warning signs to watch for that a risk is too great. While there are thousands of things that could potentially go wrong with a… 

2 Market-Beating Growth Stocks That Are Just Getting Started

The S&P 500 remains slightly in the red over the past year, but zooming out helps put things in perspective. Over the past five years, the index has delivered solid returns, and so have the corporations that were dragged down in 2022’s downturn. And even more importantly, some of these companies can still provide excellent performances over the long run for patient… 

3 Top Biotech Stocks Defying The Bear Market

The bear market for biotech stocks has recently shown signs of slackening, but there are biotech stocks whose shares are already up by 50% or more to start this year. These three have attracted investors’ interest because they all have new therapies with wide applications that have shown great promise. This post originally appeared at The Motley Fool.